Literature DB >> 27457819

[Acute pulmonary embolism and contraindication of anticoagulation : Bedside implantation of a new temporary vena cava inferior filter].

S Baumann1, T Becher2, C Jabbour2, C Fastner2, K Giannakopoulos2, M Behnes2, T Henzler3, A Alonso4, S Britsch2, D Loßnitzer2, M Borggrefe2, I Akin2.   

Abstract

Pulmonary embolism (PE), mostly caused by deep vein thrombosis, is a life-threatening complication in critically ill patients in the intensive care unit. A potential strategy to prevent PE in patients with contraindication for anticoagulant therapy is the implantation of a vena cava filter (VCF), to provide fast and safe PE protection against ascending thrombi. We report the case of a 56-year-old woman with an intracranial hemorrhage, who developed a PE. Because of acute contraindications for anticoagulant therapy, bedside implantation of a new VCF was performed to overcome the period of absolute contraindications for anticoagulation. After explanation, several thrombi were found on the filter.

Entities:  

Keywords:  Cerebral hemorrhage; Critical illness; Deep vein thrombosis; Heparin, low-molecular-weight; Prophylaxis, thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27457819     DOI: 10.1007/s00063-016-0201-9

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  16 in total

1.  [Thromboprophylaxis in the critically ill : Low molecular weight heparin versus unfractionated heparin].

Authors:  S Petros
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-15       Impact factor: 0.840

2.  Dalteparin versus unfractionated heparin in critically ill patients.

Authors:  Deborah Cook; Maureen Meade; Gordon Guyatt; Stephen Walter; Diane Heels-Ansdell; Theodore E Warkentin; Nicole Zytaruk; Mark Crowther; William Geerts; D Jamie Cooper; Shirley Vallance; Ismael Qushmaq; Marcelo Rocha; Otavio Berwanger; Nicholas E Vlahakis
Journal:  N Engl J Med       Date:  2011-03-22       Impact factor: 91.245

3.  Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism.

Authors:  Drew M Caplin; Boris Nikolic; Sanjeeva P Kalva; Suvranu Ganguli; Wael E A Saad; Darryl A Zuckerman
Journal:  J Vasc Interv Radiol       Date:  2011-09-03       Impact factor: 3.464

4.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Authors:  H Decousus; A Leizorovicz; F Parent; Y Page; B Tardy; P Girard; S Laporte; R Faivre; B Charbonnier; F G Barral; Y Huet; G Simonneau
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  Pilot study evaluating the safety of a combined central venous catheter and inferior vena cava filter in critically ill patients at high risk of pulmonary embolism.

Authors:  Carlos A Cadavid; Bladimir Gil; Alvaro Restrepo; Sergio Alvarez; Santiago Echeverry; Luis F Angel; Victor Tapson; John Kaufman
Journal:  J Vasc Interv Radiol       Date:  2013-04       Impact factor: 3.464

6.  Requiem for Liberalizing Indications for Vena Caval Filters?

Authors:  Samuel Z Goldhaber
Journal:  Circulation       Date:  2016-05-24       Impact factor: 29.690

Review 7.  Deep vein thrombosis and its prevention in critically ill adults.

Authors:  J Attia; J G Ray; D J Cook; J Douketis; J S Ginsberg; W H Geerts
Journal:  Arch Intern Med       Date:  2001-05-28

8.  Pulmonary embolism in intensive care unit: Predictive factors, clinical manifestations and outcome.

Authors:  Mabrouk Bahloul; Anis Chaari; Hatem Kallel; Leila Abid; Chokri Ben Hamida; Hassen Dammak; Noureddine Rekik; Jameleddine Mnif; Hedi Chelly; Mounir Bouaziz
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

9.  A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Victor F Tapson
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

10.  Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study.

Authors:  Richard H White; Ann Brunson; Patrick S Romano; Zhongmin Li; Ted Wun
Journal:  Circulation       Date:  2016-04-05       Impact factor: 29.690

View more
  2 in total

1.  [Bedside implantation of a new temporary vena cava inferior filter : German results from the European ANGEL registry].

Authors:  S Baumann; T Becher; K Giannakopoulos; C Jabbour; C Fastner; I El-Battrawy; U Ansari; D Lossnitzer; M Behnes; A Alonso; T Kirschning; R Dissmann; O Kueck; D Stern; G Michels; M Borggrefe; I Akin
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-03       Impact factor: 0.840

2.  Survival after cardiac arrest secondary to high-risk pulmonary embolism without reperfusion therapies: A case report.

Authors:  Cai-Yun Xu; Jia-Fu Song; Li-Hong Yao; Hui-Ling Xu; Ke-Xi Liu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.